ERBB2 and breast carcinoma: According to gene expression profile studies, TNBC may be divided into several distinct subgroups: Basal-like breast cancer (40–80%), normal-like, claudin-low, interferon-rich, molecular apocrine and HER2-enriched TNBC (32).